Medtronic MDT Other Operating Segments, Including Diabetes — Depreciation expense

Other segment segments

Similar metrics at other companies

TTMIOperating Segments — Depreciation

$37.7M-3.5%

DGXAll other operating segments — D&A

$3M-25.0%

MTDOther Operations Segment — Depreciation

$1.58M+6.7%

NDSNOperating Segments — D&A

$22.71M+29.2%

EFC

EFCCorporate Segment and Other Operating Segment — Depreciation

$0—

FICOOperating Segments — Depreciation

$5.13M-4.3%

Questions, answered.

What is Medtronic's other operating segments, including diabetes — depreciation expense?

Medtronic (MDT) reported other operating segments, including diabetes — depreciation expense of $31.75M in Q1 2026.

How has Medtronic's other operating segments, including diabetes — depreciation expense changed year-over-year?

Medtronic's other operating segments, including diabetes — depreciation expense increased by 12.4% year-over-year, from $28.25M to $31.75M.

What is the long-term trend for Medtronic's other operating segments, including diabetes — depreciation expense?

Over 2 years (2024 to 2026), Medtronic's other operating segments, including diabetes — depreciation expense has grown at a 16.2% compound annual growth rate (CAGR), from $94M to $127M.

What does other operating segments, including diabetes — depreciation expense mean?

The portion of the cost of tangible assets allocated as an expense to the secondary business segments.

How do you interpret other operating segments, including diabetes — depreciation expense?

An increase often reflects recent significant capital investments in new equipment or facilities, while a stable trend suggests consistent capital maintenance.

How does other operating segments, including diabetes — depreciation expense compare across companies?

Depreciation levels are typically compared across peers based on the degree of vertical integration and the age of the manufacturing footprint.